A review of quality of life studies in Nigerian patients with psychiatric disorders

Aloba, Olutayo; Fatoye, O; Mapayi, Boladale; Akinsulore, Adesanmi

doi:10.4314/ajpsy.v16i5.44

Cited by 14 publications

(20 citation statements)

References 34 publications

(49 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Schizophrenia and bipolar disorder are characterized by chronic, and sometimes relapsing and remitting courses that impact negatively on the premorbid functioning and quality of life of sufferers (Harding et al, 1987;Rietschel et al, 2009;Saarni et al, 2010;Latalova et al, 2011;Aloba et al, 2013). The use of medications, in conjunction with other psychosocial interventions constitutes the cornerstone in the management of these disorders (Barnes et al, 2011;Goodwin et al, 2009).…”

Section: Introductionmentioning

confidence: 99%

Medication-related factors of non adherence among patients with schizophrenia and bipolar disorder: Outcome of a cross-sectional survey in Maiduguri, North-eastern Nigeria

Ibrahim¹,

W²,

Pindar³

et al. 2015

J. Neurosci. Behav. Health

View full text Add to dashboard Cite

Pharmacotherapy is the cornerstone in the symptomatic treatment of schizophrenia and bipolar disorder, but non-adherence to the medications constitutes major obstacles to optimal outcome in their management. This study assessed the prevalence of and exclusively x-rayed medication-related factors of non-adherence among patients with these disorders in a resource-poor setting. Three hundred and fifty eight (358)

show abstract

Section: Introductionmentioning

confidence: 99%

Medication-related factors of non adherence among patients with schizophrenia and bipolar disorder: Outcome of a cross-sectional survey in Maiduguri, North-eastern Nigeria

Ibrahim¹,

W²,

Pindar³

et al. 2015

J. Neurosci. Behav. Health

View full text Add to dashboard Cite

show abstract

“…The domains are: Physical Functioning (SF), Role Impairment due to Physical Problem (RIPP), Role Impairment due to Emotional Problems (RIEP), Bodily Pain (BP), Vitality (V), Societal Functioning (SF), Mental Health (MH) and General Health Perception (GHP). In this survey, item internal consistency was high (Cranach's alpha>0.7) and item discriminate variability was low for all items except for vitality which varied between 0.28 and 0.61 [21].…”

Section: Methodsmentioning

confidence: 96%

Impact of Self Stigma on Quality of Life of People with Mental Illness at Dilla University Referral Hospital, South Ethiopia

Ayenalem¹

2017

AJHR

View full text Add to dashboard Cite

Abstract:The stigma associated with mental illness can potentially be a reason for lower quality of life among persons with mental illness. Since self stigma can also exist without actual stigma from the public, more hidden and inside, it seems to be the worst form of stigma against people with mental illness and can directly affect the overall well being of people with mental illness. Moreover, it is also a great barrier for social interaction. However, no study is available on impact of self stigma on quality of life of people with mental illness in South Ethiopia generally and particularly in Dilla town. The purpose of this study was to assess the impact of self stigma on quality of life of people with mental illness at Dilla University Referral Hospital, south Ethiopia. The study was conducted in the psychiatry outpatient department of Dilla University referral hospital. An institutional based cross-sectional study was conducted on 317 people with mental illness that attended psychiatric clinic for mental health service from June 1 st to 30 th , 2016. Data were collected using a pre tested interviewer administered structured questionnaires. Self-stigma was measured using Internalized Stigma of Mental Illness (ISMI) Scale which was validated and used in many other similar settings. Quality of life was measured using quality of life assessment tool Short Form, Version-2 (SF-36). In this study, the prevalence of self stigma among people with mental illness was 32.1%. Regarding Quality of life (QoL) of people with mental illness, 54.6% were experiencing lower quality of life. As self stigma increases by one unit in studied participants, quality of life decreases by 4.1% (OR=0.041; 95% C.I: -0.065,-0.012). In other words, self stigma and QOL were inversely correlated(r=-0.076) which indicates that stigma worsen QoL of people with mental illness. The result of this study was revealed that, apparently high prevalence of self-stigma among persons with mental illness and lower quality of life. To improve QoL of people with mental illness, tackling stigma need to be addressed by health professionals, community, researchers, policy makers and stakeholders.

show abstract

“…The concept of quality of life (QoL) is becoming an increasingly important measure of the impact of psychiatric disorders and is now recognized as useful in the health-care evaluation of patients with psychiatric disorders. [ 1 ] The concept of QoL has progressively shifted from a strictly sociological and objective prospective to a psychosocial prospective in which the individual's sense of well-being becomes a primary dimension of QoL. [ 2 ]…”

Section: Introductionmentioning

confidence: 99%

A cross-sectional comparative study on the assessment of quality of life in psychiatric patients under remission treated with monotherapy and polypharmacy

Koshy¹,

Das²,

Rajashekarachar³

et al. 2017

Indian J Psychiatry

View full text Add to dashboard Cite

Context:The concept of quality of life (QoL) is becoming an important measure of the impact of psychiatric disorders. It is natural that once patient achieves remission, QoL would improve, but very few studies are conducted under this phase. This study compares the differences in QoL in remitted patients with monotherapy and polypharmacy.Aims:The aim of this study is to compare the QoL between psychiatric patients in remission treated with monotherapy and polypharmacy.Settings and Design:It is a questionnaire based cross-sectional comparative study.Materials and Methods:This study included outpatients under remission who come for follow-up in psychiatric department. Semi-structured data collection form was used. Remission was confirmed using suitable scales, and QoL was assessed using the World Health Organization quality of life-Brief (WHOQOL-BREF) scale. Clinical Global Impression (CGI) and Global Assessment of Functioning (GAF) were applied to understand the overall improvement and functioning levels.Results:Out of the total 100 patients enrolled in the study, fifty patients were on monotherapy and fifty patients on polypharmacy. The cost of medication was comparatively high for polypharmacy (Rs. 3568.92 [±348.54]) than monotherapy (Rs. 1936.56 [±252.07]). The QoL in physical, psychological, and social domains was significantly high in patients on polypharmacy rather than monotherapy when assessed using the WHOQOL-BREF scale. Ninety-six percent of monotherapy patients had CGI scores between 1.5 and 2.4 while 74% of polypharmacy patients had scores between 1.0 and 1.5. Ninety-six percent of monotherapy patients had <80 GAF scores while 92% of polypharmacy patients had >80.Conclusions:Patients treated with polypharmacy had better QoL and also clinical improvement and functioning levels were superior.

show abstract

A review of quality of life studies in Nigerian patients with psychiatric disorders

Cited by 14 publications

References 34 publications

Medication-related factors of non adherence among patients with schizophrenia and bipolar disorder: Outcome of a cross-sectional survey in Maiduguri, North-eastern Nigeria

Medication-related factors of non adherence among patients with schizophrenia and bipolar disorder: Outcome of a cross-sectional survey in Maiduguri, North-eastern Nigeria

Impact of Self Stigma on Quality of Life of People with Mental Illness at Dilla University Referral Hospital, South Ethiopia

A cross-sectional comparative study on the assessment of quality of life in psychiatric patients under remission treated with monotherapy and polypharmacy

Contact Info

Product

Resources

About